| 20 Aug, 07:02 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Change in Company Secretary/Compliance Officer | nse |
| 20 Aug, 07:01 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Appointment of Company Secretary and Compliance Officer | bse |
| 10 Aug, 07:07 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP | nse |
| 10 Aug, 07:01 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding Resignation of Ms. Manisha Saraf as Company Secretary & Compliance Officer of the company w.e.f. August 11, 2026. | nse |
| 10 Aug, 07:00 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | bse |
| 10 Aug, 12:54 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 10 Aug, 12:52 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Transcript | nse |
| 04 Aug, 07:31 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 04 Aug, 07:28 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Link of Recording | nse |
| 04 Aug, 02:51 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a revised press release dated August 04, 2026, titled "Revised Press Release on the Unaudited Financial Results for the quarter ended30th June, 2026.". | nse |
| 04 Aug, 02:51 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) | bse |
| 04 Aug, 02:20 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 04 Aug, 02:20 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 04, 2026, titled "Press Release on the Unaudited Financial Results for the quarter ended30th June, 2026.". | nse |
| 04 Aug, 02:17 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 04 Aug, 02:14 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation | nse |
| 04 Aug, 02:10 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Unaudited Financial Results For The Quarter Ended June 30, 2026 | bse |
| 04 Aug, 02:10 pm | — | … | Alembic Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | nse |
| 04 Aug, 02:05 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 04, 2026. | nse |
| 28 Jul, 01:26 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 28, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Prucalopride Tablets, 1 mg and 2 mg.". | nse |
| 28 Jul, 01:23 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 27 Jul, 06:00 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Schedule of Post Results Conference Call on Tuesday, 4th August, 2026 | nse |
| 24 Jul, 05:58 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Board Meeting Intimation for Board Meeting To Consider Unaudited Financial Results For The Quarter Ended 30Th June, 2026. | bse |
| 18 Jul, 08:38 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 18 Jul, 08:35 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 18, 2026, titled "Alembic Pharmaceuticals Limited's Partner NATCO Pharma Limited receives USFDA Tentative Approval for Olaparib Tablets, 100 mg and 150 mg". | nse |
| 13 Jul, 06:41 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about General Updates Disclsoure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 10 Jul, 07:06 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding 'Specimen Copy Of The Letter Sent To The Shareholders Under Regulation 36(1)(b) Of SEBI LODR'. | nse |
| 10 Jul, 04:54 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 29-Jul-2026. | nse |
| 10 Jul, 04:53 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Intimation Of Record Date For Payment Of Dividend On Equity Shares For The Financial Year Ended 31St March, 2026. | bse |
| 10 Jul, 04:27 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Reg. 34 (1) Annual Report. | bse |
| 01 Jul, 06:43 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Credit Rating | bse |
| 01 Jul, 06:40 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Credit Rating | nse |
| 26 Jun, 07:11 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 26 Jun, 07:10 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 26, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dapsone Gel, 5%.". | nse |
| 26 Jun, 10:31 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 26 Jun, 10:31 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 26, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Oseltamivir Phosphate for Oral Suspension, 6 mg/mL.". | nse |
| 19 Jun, 01:00 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 19, 2026, titled "Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Binimetinib Tablets, 45 mg". | nse |
| 19 Jun, 12:57 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 18 Jun, 09:34 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 18 Jun, 09:32 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr. Sujit Bhayani as Non- Executive Independent Director of the company w.e.f. Jun 18, 2026. | nse |
| 12 Jun, 12:43 pm | regulatory_action | 2 | Alembic Pharmaceuticals received USFDA final approval for Tretinoin Cream USP 0.05% as per a Jun 12, 2026 press release. | nse |
| 11 Jun, 09:52 pm | rating_action | 1 | Alembic Pharmaceuticals Limited informed the Exchange about a credit rating update from CRISIL Ratings Limited. | nse |
| 11 Jun, 12:37 pm | other | 2 | Alembic Pharmaceuticals received USFDA tentative approval for Larotrectinib capsules (25 mg and 100 mg) per a Jun 11, 2026 press release. | nse |
| 06 Jun, 04:05 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Agreements | nse |
| 06 Jun, 04:05 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 05 Jun, 05:36 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about General Updates: Specimen copy of the reminder letter sent to the shareholders of the Company holding shares in physical form for updating their KYC details. | nse |
| 05 Jun, 05:35 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 | bse |
| 05 Jun, 10:52 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 05 Jun, 10:50 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 05, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Haloperidol Tablets, USP." | nse |
| 03 Jun, 06:32 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 03 Jun, 06:32 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about change in Management | nse |